Company Overview and News

0
SuperSonic Imagine to Feature Aixplorer, the Only Ultrasound Imaging device with 510(k) Approval for Management of Liver Disease, at Digestive Disease Week 2018

2018-05-30 globenewswire
AIX-EN-PROVENCE, France, May 30, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will feature the Aixplorer® platform at Digestive Disease Week (DDW) 2018, held June 2 – 5 at Walter E. Washington Convention Center in Washington, D.C. The Aixplorer platform, which includes the Aixplorer and Aixplorer Ultimate ultrasound systems, is the only imaging ultrasound device platform to receive 510(k) clearance from the U.
SSI

0
Aixplorer Mach 30 SuperSonic Imagine Pushes the Boundaries of Ultrasound Imaging

2018-04-25 globenewswire
AIX-EN-PROVENCE, France, April 25, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814, PEA-PME eligible), a company specializing in ultrasound medical imaging, today announced the launch of its new cutting-edge smart Ultrasound Platform, Aixplorer Mach 30.
SSI

0
Aixplorer® Ultimate Ultrasound to Be Featured by SuperSonic Imagine at SBI/ACR Breast Imaging Symposium

2018-04-11 globenewswire
AIX-EN-PROVENCE, France, April 11, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814), a company specializing in ultrasound medical imaging, today announced that it will feature the Aixplorer® Ultimate premium ultrasound platform at the 2018 Society of Breast Imaging/American College of Radiology Breast Imaging Symposium (SBI 2018), held April 12-15 in Las Vegas. The Aixplorer Ultimate is the only UltraFast™ ultrasound system, featuring enhanced performance, workflow and efficiency, as well as a combination of impeccable image quality and unprecedented ultrasound advances.
SSI

0
SuperSonic Imagine Showcasing Aixplorer Ultimate During the International Liver Congress (ILC) 2018

2018-04-09 globenewswire
AIX-EN-PROVENCE, France, April 09, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext:SSI) (FR0010526814, PME), a company specialising in medical imaging using ultrasound technology, announced it will attend the International Liver Congress (ILC), organised by the European Association for the Study of the Liver (EASL), in Paris from April 11 – 15.
SSI

0
SuperSonic Imagine’s Aixplorer® Ultimate Highlighted at American Institute of Ultrasound in Medicine Meeting in New York

2018-03-21 globenewswire
Aix-en-Provence, France, March 21, 2018 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI) (FR0010526814), a company specializing in ultrasound medical imaging, announced today that it will highlight its premium ultrasound platform at the American Institute of Ultrasound in Medicine (AIUM) 2018 meeting in New York City, March 24-28. The Aixplorer Ultimate, the only UltraFast™ ultrasound system, offers enhanced performance, workflow and efficiency, as well as a combination of impeccable image quality and important ultrasound advances.
SSI

Related Articles

CATB: Catabasis Pharmaceuticals Analysis and Research Report

2018-07-13 - Asif

Overview Catabasis Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutics based on its proprietary Safely Metabolized And Rationally Targeted linker, or SMART LinkerSM, drug discovery platform. The company's SMART Linker drug discovery platform enables it to engineer product candidates that can simultaneously modulate multiple targets in a disease. The company's proprietary product candidates impact pathways that are central to diseases where efficacy may be optimized by a multiple target approach. Catabasis Pharmaceuticals has applied its SMART Linker drug discovery platform to build an internal pipeline of product candidates for rare diseases, its primary focus, and plan to pursue partnerships to develop additional product candidates. The company's lead product candidate is edasalonexent, formerly known as CAT-1004, which the company believe has the potential to be a disease-modifying...

WMT: Walmart Analysis and Research Report

2018-07-09 - Asif

Overview Walmart Inc. helps people around the world save money and live better – anytime and anywhere – in retail stores and through eCommerce. Through innovation, Walmart is striving to create a customer-centric experience that seamlessly integrates its eCommerce and retail stores in an omni-channel offering that saves time for its customers. Each week, the company serve nearly 270 million customers who visit its more than 11,700 stores and numerous eCommerce websites under 65 banners in 28 countries. The company's strategy is to lead on price, invest to differentiate on access, be competitive on assortment and deliver a great experience. Leading on price is designed to earn the trust of its customers every day by providing a broad assortment of quality merchandise and services at everyday low prices ("EDLP"). EDLP is its pricing philosophy under which the company price items at a low price every day so its customers trust that its prices will not change under frequent prom...

NVRO: Nevro Corp Analysis and Research Report

2018-07-06 - Asif

Overview Nevro is a global medical device company focused on providing innovative products that improve the quality of life of patients suffering from chronic pain. Nevro has developed and commercialized the Senza® spinal cord stimulation (SCS) system, an evidence-based neuromodulation platform for the treatment of chronic pain. The company's proprietary paresthesia-free HF10TM therapy, delivered by its Senza system, was demonstrated in its SENZA-RCT study to be superior to traditional SCS therapy with it being nearly twice as successful in treating back pain and 1.5 times as successful in treating leg pain when compared to traditional SCS therapy. Comparatively, traditional SCS therapy has limited efficacy in treating back pain and is used primarily for treating leg pain, limiting its market adoption. The company's SENZA-RCT study, along with its European studies, represents what the company believe is the most robust body of clinical evidence for any SCS therapy. The compa...

Silicon Investor Message Boards

This table lists all message boards related to EPA:SSI / SUPERSONIC IMAGINE on message board site Silicon Investor.

Classic TA Workplace Foreign Policy Discussion Thread
Silicon Investor - New feature discussion Mozilla: Firefox and Thunderbird Discussion ...
Libertarian Discussion Forum Quarter to Quarter Aggressive Growth Stocks
Missing Persons SI Thread TGL WHAAAAAAAT! Alerts, thoughts, discussion.
Foreign Affairs Discussion Group NNVC Keeping it real board for pro and con discussions